Mike Lam

Mike represents high-growth companies and investment banks in capital markets and corporate transactions, including initial public offerings (IPOs), other equity offerings, high-yield and investment-grade offerings, and acquisition financing. Mike also has experience counseling clients on general corporate and securities matters, including M&A, private equity and venture capital investments, US Securities and Exchange Commission reporting obligations, and corporate governance. He has advised on these issues as both in-house counsel at NVIDIA and as outside counsel to public and private companies.

Mike’s representative matters include advising:

Capital markets

• Grindr on its $2.1 billion de-SPAC (special purpose acquisition company) business combination with Tiga Acquisition Corp. and its ongoing corporate and public company matters
• Heliogen on its $2 billion de-SPAC business combination with Athena Technology Acquisition Corp.
• Annexon Biosciences on its $125 million registered direct offering
• Aspira Women’s Health on its $5.5 million registered direct offering, concurrent private placement, and ongoing corporate and public company matters
• Resideo on its $255 million follow-on offering*
• The underwriters in Sagimet Biosciences’:
  • $85 million IPO
  • $112.5 million follow-on offering
• The underwriters in Apogee Therapeutics’ $345.1 million IPO
• The underwriters in DICE Therapeutics’ $234.6 million IPO
• The underwriters in Ventyx Biosciences’ $174.3 million IPO
• The underwriters in Qualtrics’ $1.15 billion follow-on offering
• The underwriters in 89bio’s $172.5 million follow-on offering
• The underwriters and initial purchasers in Ascendis Pharma’s:
  • $460 million follow-on offering
  • $575 million offering of 2.25% convertible senior notes due 2028
• The initial purchasers in Global Blood Therapeutics’ $345 million offering of 1.875% convertible senior notes due 2028
• The underwriters in IGM Biosciences’:
  • $230 million follow-on offering
  • $97.5 million follow-on offering
  • $22.5 million concurrent private placement
• The underwriters in Arcutis’ $172.5 million follow-on offering
• The underwriters in LumiraDX’s $75.3 million follow-on offering and $25 million concurrent private placement
• The underwriters in Vistagen Therapeutics’ $100 million follow-on offering
• The underwriters in Erasca’s $100 million follow-on offering
• The underwriters in Acutus Medical’s $77 million follow-on offering
• The placement agents in Annexon Biosciences’ $130 million private placement

M&A, private equity, and emerging companies and venture capital

• Several buy-side mergers and acquisitions of tech and artificial intelligence companies while at NVIDIA*
• Bloomberg on several corporate transactions*
• Atlas Holdings on its acquisition of LSC Communications, pursuant to Section 363 of the US Bankruptcy Code*
• Platinum Equity on certain corporate transactions*
• Warburg Pincus on certain private equity investments*
• Cisco on its acquisition of ThousandEyes*
• Brinker Capital on its sale to Genstar Capital and subsequent merger with Orion Advisor Solutions*
• Exela Technologies on its:
  • $160 million accounts receivable securitization facility*
  • Carve-out sale of SourceHOV Tax to Gainline Capital Partners*
  • Corporate and public company matters*
• Andreessen Horowitz on its investment in the $20 million Series A financing of Stacker
• Altos Labs on certain private company matters
• Full In Partners on its investment in the Series B financing of AutoRABIT*
• Insight Partners on its investments in:
  • The Real Brokerage*
  • Hinge Health*

* Representation handled before joining Cooley

Before joining Cooley, Mike was a corporate counsel at NVIDIA and a corporate associate in the New York office of another US-based international law firm.

During law school, Mike represented social enterprises, nonprofit organizations and select small businesses as a student attorney in the Social Enterprise and Nonprofit Law Clinic, served as a staff editor and community outreach director of the Georgetown Journal on Poverty Law and Policy, and worked as a research assistant for Robert B. Thompson, professor of business law. He also externed in the Division of Enforcement’s Whistleblower Office of the US Commodity Futures Trading Commission.

Before law school, Mike worked in several roles in the channel operations, compensation and marketing departments of a Canadian telecommunications provider, where he helped develop and implement strategic marketing initiatives, incentive programs and channel compensation systems.